Trial no.:
|
PACTR20180770451482 |
Date of Approval:
|
26/07/2018 |
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
TRIAL DESCRIPTION |
Public title
|
Effect of Glucosamine Sulfate, Chondrotin Sulfate, Methylsulfonylmethane Phonophoresis on Pain, Range of Motion, Position Sense and function in Knee Osteoarthritis |
Official scientific title |
Glucosamine Sulfate, Chondrotin Sulfate, Methylsulfonylmethane Phonophoresis on Knee Osteoarthritis |
Brief summary describing the background
and objectives of the trial
|
Glucosamine sulfate and chondroitin sulfate are believed to relieve pain, decrease joint narrowing, stimulate the production of new cartilage components, and help the body to repair damaged cartilage. Methylsulfonylmethane is an analgesic and anti-inflammatory drug is usually used with the previous drugs. Phonophoresis was believed to influence drug delivery by increasing cell permeability, causing particle oscillations within the tissue and drug milieu. This trial was designed to investigate the effect of Glucosamine sulfate, chondroitin sulfate and Methylsulfonylmethane Phonophoresis (PH) in knee osteoarthritis (OA). |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Musculoskeletal Diseases |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Drugs |
Anticipated trial start date |
18/01/2018 |
Actual trial start date |
|
Anticipated date of last follow up |
30/04/2018 |
Actual Last follow-up date |
|
Anticipated target sample size (number of participants) |
70 |
Actual target sample size (number of participants) |
|
Recruitment status |
Stopped early/ terminated |
Publication URL |
|
|